• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡介苗纤连蛋白附着蛋白在卡介苗诱导的抗肿瘤活性中的作用。

Role of a bacillus Calmette-Guérin fibronectin attachment protein in BCG-induced antitumor activity.

作者信息

Zhao W, Schorey J S, Bong-Mastek M, Ritchey J, Brown E J, Ratliff T L

机构信息

Department of Urology, University of Iowa, Iowa City 52242-1089, USA.

出版信息

Int J Cancer. 2000 Apr 1;86(1):83-8. doi: 10.1002/(sici)1097-0215(20000401)86:1<83::aid-ijc13>3.0.co;2-r.

DOI:10.1002/(sici)1097-0215(20000401)86:1<83::aid-ijc13>3.0.co;2-r
PMID:10728599
Abstract

Intravesical Mycobacterium bovis bacillus Calmette-Gu*erin (BCG) is the treatment of choice for superficial bladder cancer. Previous studies showed that attachment of BCG to fibronectin within the bladder was necessary for mediation of the antitumor response. Further studies identified a bacterial receptor, fibronectin attachment protein (FAP), as an important mediator of BCG attachment to fibronectin. In vitro studies showed that a stable BCG/fibronectin interaction was dependent on FAP binding to fibronectin; however, no role for FAP in the attachment of BCG in vivo has been characterized. We now report the cloning of the M. bovis BCG FAP (FAP-B) and demonstrate an important role for FAP in the in vivo attachment of BCG to the bladder wall and in the induction of BCG-mediated antitumor activity. The predicted amino acid sequence for FAP-B shows 61% and 71% homology, respectively, with Mycobacterium avium FAP (FAP-A) and Mycobacterium leprae FAP (FAP-L). Rabbit polyclonal antibodies against Mycobacterium vaccae FAP (FAP-V) reacted with all 3 recombinant FAP proteins on Western blots. Functional studies show FAP-B to bind fibronectin via the highly conserved attachment regions previously identified for FAP-A and FAP-L and also to competitively inhibit attachment of BCG to matrix fibronectin. In vivo studies show FAP to be a necessary protein for the stable attachment of BCG to the bladder wall. Moreover, stable binding of BCG via FAP was shown to be necessary for the expression of BCG-induced antitumor activity. Our results demonstrate a biological role for FAP in the mediation of BCG-induced antitumor activity.

摘要

膀胱内注射卡介苗(BCG)是浅表性膀胱癌的首选治疗方法。先前的研究表明,BCG在膀胱内与纤连蛋白结合是介导抗肿瘤反应所必需的。进一步的研究确定了一种细菌受体,即纤连蛋白附着蛋白(FAP),是BCG与纤连蛋白结合的重要介质。体外研究表明,稳定的BCG/纤连蛋白相互作用依赖于FAP与纤连蛋白的结合;然而,FAP在BCG体内附着中的作用尚未得到明确。我们现在报告牛分枝杆菌BCG FAP(FAP-B)的克隆,并证明FAP在BCG体内附着于膀胱壁以及诱导BCG介导的抗肿瘤活性中起重要作用。FAP-B的预测氨基酸序列分别与鸟分枝杆菌FAP(FAP-A)和麻风分枝杆菌FAP(FAP-L)具有61%和71%的同源性。抗母牛分枝杆菌FAP(FAP-V)的兔多克隆抗体在蛋白质印迹上与所有3种重组FAP蛋白发生反应。功能研究表明,FAP-B通过先前为FAP-A和FAP-L确定的高度保守的附着区域与纤连蛋白结合,并且还竞争性抑制BCG与基质纤连蛋白的附着。体内研究表明,FAP是BCG稳定附着于膀胱壁所必需的蛋白质。此外,通过FAP的BCG稳定结合被证明是BCG诱导的抗肿瘤活性表达所必需的。我们的结果证明了FAP在介导BCG诱导的抗肿瘤活性中的生物学作用。

相似文献

1
Role of a bacillus Calmette-Guérin fibronectin attachment protein in BCG-induced antitumor activity.卡介苗纤连蛋白附着蛋白在卡介苗诱导的抗肿瘤活性中的作用。
Int J Cancer. 2000 Apr 1;86(1):83-8. doi: 10.1002/(sici)1097-0215(20000401)86:1<83::aid-ijc13>3.0.co;2-r.
2
The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity.卡介苗(BCG)的纤连蛋白附着蛋白介导抗肿瘤活性。
Cancer Immunol Immunother. 2008 Apr;57(4):573-9. doi: 10.1007/s00262-007-0397-x. Epub 2007 Sep 5.
3
Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.卡介苗膀胱内灌注治疗小鼠膀胱肿瘤:卡介苗通过纤连蛋白介导的黏附引发反应。
Cancer Res. 1987 Apr 1;47(7):1762-6.
4
Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria.鸟分枝杆菌纤连蛋白附着蛋白的特性揭示了分枝杆菌中保守的纤连蛋白结合基序。
Mol Microbiol. 1996 Jul;21(2):321-9. doi: 10.1046/j.1365-2958.1996.6381353.x.
5
Modulation of fibronectin-mediated Bacillus Calmette-Guérin attachment to murine bladder mucosa by drugs influencing the coagulation pathways.通过影响凝血途径的药物调节纤连蛋白介导的卡介苗对小鼠膀胱黏膜的黏附
Cancer Res. 1991 Jul 15;51(14):3726-32.
6
Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.纤连蛋白介导卡介苗与小鼠膀胱黏膜的附着。抗肿瘤反应表达的必要性。
J Clin Invest. 1990 Jan;85(1):62-7. doi: 10.1172/JCI114434.
7
Role of fibronectin in intravesical BCG therapy for superficial bladder cancer.纤连蛋白在浅表性膀胱癌膀胱内卡介苗治疗中的作用。
J Urol. 1988 Feb;139(2):410-4. doi: 10.1016/s0022-5347(17)42445-1.
8
Specific binding of bacillus Calmette-Guérin to urothelial tumor cells in vitro.卡介苗在体外与尿路上皮肿瘤细胞的特异性结合。
World J Urol. 1994;12(6):337-44. doi: 10.1007/BF00184116.
9
Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAP.一种独特的分枝杆菌纤连蛋白附着蛋白FAP的纤连蛋白结合基序的表征
J Biol Chem. 1999 Feb 19;274(8):4521-6. doi: 10.1074/jbc.274.8.4521.
10
Fibronectin attachment protein from bacillus Calmette-Guerin as targeting agent for bladder tumor cells.卡介苗纤维连接蛋白附着蛋白作为膀胱肿瘤细胞的靶向剂。
Int J Cancer. 2012 Aug 1;131(3):591-600. doi: 10.1002/ijc.26413. Epub 2011 Oct 20.

引用本文的文献

1
BCG therapy in bladder cancer and its tumor microenvironment interactions.卡介苗治疗膀胱癌及其与肿瘤微环境的相互作用。
Clin Microbiol Rev. 2025 Jun 12;38(2):e0021224. doi: 10.1128/cmr.00212-24. Epub 2025 Mar 20.
2
Microbiome in urologic neoplasms: focusing on tumor immunity.泌尿系统肿瘤中的微生物群:聚焦肿瘤免疫
Front Immunol. 2024 Dec 5;15:1507355. doi: 10.3389/fimmu.2024.1507355. eCollection 2024.
3
Exploring the Immunoresponse in Bladder Cancer Immunotherapy.探索膀胱癌免疫治疗中的免疫反应。
Cells. 2024 Nov 22;13(23):1937. doi: 10.3390/cells13231937.
4
Revitalizing Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches.恢复卡介苗对膀胱癌的免疫治疗:纳米技术与生物工程方法
Pharmaceutics. 2024 Aug 15;16(8):1067. doi: 10.3390/pharmaceutics16081067.
5
The Role of Tumor and Host Microbiome on Immunotherapy Response in Urologic Cancers.肿瘤和宿主微生物群在泌尿生殖系统癌症免疫治疗反应中的作用
J Cancer Immunol (Wilmington). 2024;6(1):1-13. doi: 10.33696/cancerimmunol.6.078.
6
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer.联合使用软骨素和透明质酸膀胱灌注治疗卡介苗诱导的膀胱癌膀胱炎
J Clin Med. 2024 Mar 31;13(7):2031. doi: 10.3390/jcm13072031.
7
Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria.破解实体瘤的免疫反应:利用溶瘤细菌的抗癌能力
Pharmaceutics. 2023 Jul 21;15(7):2004. doi: 10.3390/pharmaceutics15072004.
8
Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma.膀胱内卡介苗作为膀胱癌治疗性疫苗的作用。
Iran Biomed J. 2022 Nov 1;26(5):340-9. doi: 10.52547/ibj.3676.
9
The Urinary Microbiome: Role in Bladder Cancer and Treatment.泌尿微生物组:在膀胱癌及治疗中的作用
Diagnostics (Basel). 2022 Aug 26;12(9):2068. doi: 10.3390/diagnostics12092068.
10
BCG in Bladder Cancer Immunotherapy.卡介苗在膀胱癌免疫治疗中的应用
Cancers (Basel). 2022 Jun 23;14(13):3073. doi: 10.3390/cancers14133073.